enGene Therapeutics Inc. SEC filings ENGNW
enGene Therapeutics Inc. has 267 filings in SEC EDGAR's recent list, going back to Jun 14, 2023. Its latest annual report, Form ARS, was filed on May 8, 2026 for the period ended Oct 31, 2025. The latest quarterly report (Form 10-Q) was filed on Sep 8, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (results of operations). The company's fiscal year ends on October 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| 3 | Initial insider ownership | Jul 22, 2026 | Jul 16, 2026 |
| 3 | Initial insider ownership | Jul 22, 2026 | Jul 16, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 22, 2026 | — |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Jan 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 27, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 18, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 4 | Insider transaction | Oct 1, 2025 | Sep 30, 2025 |
| 3 | Initial insider ownership | Oct 1, 2025 | Sep 29, 2025 |
| 4 | Insider transaction | Jul 14, 2025 | Jul 8, 2025 |
| 3 | Initial insider ownership | Jul 14, 2025 | Jul 8, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| 4 | Insider transaction | Jul 10, 2025 | Jul 8, 2025 |
| 3 | Initial insider ownership | Jul 8, 2025 | Jul 8, 2025 |
| 3 | Initial insider ownership | Jul 8, 2025 | Jul 8, 2025 |
| 3 | Initial insider ownership | Jul 8, 2025 | Jul 8, 2025 |
| 3 | Initial insider ownership | Jul 8, 2025 | Jul 8, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 16, 2025 |
| 3 | Initial insider ownership | May 29, 2025 | May 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 29, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 29, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| 4 | Insider transaction | Nov 1, 2024 | Oct 30, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Nov 1, 2024 | — |
| 4 | Insider transaction | Oct 22, 2024 | Oct 21, 2024 |
| 4 | Insider transaction | Oct 22, 2024 | Oct 21, 2024 |
| 3 | Initial insider ownership | Oct 22, 2024 | Oct 21, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 21, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 18, 2024 | — |
| 4 | Insider transaction | Oct 18, 2024 | Dec 27, 2023 |
| 4 | Insider transaction | Oct 1, 2024 | Sep 27, 2024 |
| 4 | Insider transaction | Jul 25, 2024 | Jul 24, 2024 |
| 3 | Initial insider ownership | Jul 25, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 24, 2024 | Jul 22, 2024 |
| 3 | Initial insider ownership | Jul 24, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 15, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 15, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 15, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 15, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 15, 2024 |
| 4 | Insider transaction | Jun 18, 2024 | Jun 15, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 28, 2024 |
| 3 | Initial insider ownership | May 17, 2024 | May 15, 2024 |
| 3 | Initial insider ownership | May 17, 2024 | May 15, 2024 |
| 4 | Insider transaction | Apr 22, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Mar 25, 2024 | Mar 21, 2024 |
| 4 | Insider transaction | Mar 20, 2024 | Mar 18, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 26, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 23, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 23, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 22, 2024 | — |
| 4 | Insider transaction | Feb 21, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 21, 2024 | Feb 20, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 21, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 3 | Initial insider ownership | Feb 2, 2024 | Jan 29, 2024 |
| 3 | Initial insider ownership | Dec 19, 2023 | Dec 18, 2023 |
| 4 | Insider transaction | Dec 4, 2023 | Nov 30, 2023 |
| 4 | Insider transaction | Dec 4, 2023 | Nov 30, 2023 |
| 3 | Initial insider ownership | Nov 29, 2023 | Nov 27, 2023 |
| 3 | Initial insider ownership | Nov 13, 2023 | Oct 31, 2023 |
| SC 13G | Ownership over 5% (passive) | Nov 13, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Nov 13, 2023 | — |
| 3 | Initial insider ownership | Nov 13, 2023 | Oct 31, 2023 |
| SC 13D | Ownership over 5% (active) | Nov 13, 2023 | — |
| SC 13D | Ownership over 5% (active) | Nov 8, 2023 | — |
| 3 | Initial insider ownership | Nov 7, 2023 | Oct 31, 2023 |
| SC 13G | Ownership over 5% (passive) | Nov 7, 2023 | — |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Nov 2, 2023 | Oct 30, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
| 3 | Initial insider ownership | Oct 31, 2023 | Oct 31, 2023 |
Showing 140 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ENGN (Nasdaq), ENGNW (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Saint-Laurent
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1980845
- Former names
- enGene Holdings Inc. (until Mar 9, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.